Orange Book product · Generic (ANDA)
METHIMAZOLE
METHIMAZOLE
At a glance
Mar 27, 2001
Approved
Generic (ANDA)
Application
AB
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Mar 27, 2001
25 yr 7 mo ago
Today
Pharmaceutical detail
Active ingredient
METHIMAZOLE
Strength
5MG
Dosage form
TABLET
Route
ORAL
TE code
AB
Application
ANDA 040411
Product number
001
Marketing status
RX
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of METHIMAZOLE
- —TAPAZOLEBrand (NDA)
NDA 007517 · KING PHARMS
- 2025METHIMAZOLEGeneric (ANDA)
ANDA 218830 · SQUARE PHARMS PLC
- 2023METHIMAZOLEGeneric (ANDA)
ANDA 218149 · BIONPHARMA
- 2023METHIMAZOLEGeneric (ANDA)
ANDA 209827 · MACLEODS PHARMS LTD
- 2012METHIMAZOLEGeneric (ANDA)
ANDA 202068 · RISING
- 2007METHIMAZOLEGeneric (ANDA)
ANDA 040734 · HERITAGE PHARMA
- 2007METHIMAZOLEGeneric (ANDA)
ANDA 040870 · SUN PHARM INDS INC
- 2005METHIMAZOLEGeneric (ANDA)
ANDA 040619 · DISCOVERY THERAP
- 2005METHIMAZOLEGeneric (ANDA)
ANDA 040547 · AIPING PHARM INC
- 2000TAPAZOLEGeneric (ANDA)
ANDA 040320 · KING PHARMS LLC
- 2000METHIMAZOLEGeneric (ANDA)
ANDA 040350 · MYLAN
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
